Japan - Regenerative Medicine Market by Application and Technology - Forecast and Analysis 2023-2027

Published: Oct 2023

Pages: 127

SKU: IRTNTR76343

Snapshot

Japan - Regenerative Medicine Market 2023-2027

Japan - regenerative medicine market size is estimated to grow by USD 2,328.47 million at a CAGR of 15.89% between 2022 and 2027.

Stem cell therapy is a rapidly developing technology that can be applied to regenerative medicine. The use of stem cell technology in the treatment of diseases has increased its adoption rate. Furthermore, technological advances in stem cell-based therapies are changing the way researchers view regenerative medicine and are an important driver of these medical developments. Nanotechnology is also becoming increasingly important as a crucial tool in stem cell technology and regenerative medicine. Consequently, the growing adoption of stem cell technology will drive Japan regenerative medicine market size growth during the forecast period.

Technavio has segmented the market into Application, and Technology

The application segment includes oncology, musculoskeletal, dermatology, immunology and inflammation, and others.
The technology segment includes cell and tissue-based, and gene therapy.

This regenerative medicine market report also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the size of the Japan Regenerative Medicine Market During the Forecast Period?

To learn more about this report, Request Free Sample

Japan Regenerative Medicine Market Analysis

Application Analysis

Oncology

The market share growth by the oncology segment will be significant during the forecast period. Regenerative therapy is used to increase the ability of a patient's immune system to fight cancer. Oncology regenerative medicine treats blood-related diseases such as non-Hodgkin's lymphoma, Hodgkin's lymphoma, multiple myeloma, and leukemia. For example, the monoclonal antibody rituximab (Rituxan) is used to treat lymphoma and leukemia, and lenalidomide (Revlimid) can be used for multiple myeloma.

Get a glance at the market contribution of various segments View a PDF Sample

The oncology segment was valued at USD 417.64 million in 2017. This segment is driven by factors such as the rising incidence of cancer in Japan. Therefore, there is a growing need for effective oncology regenerative medicine. Additionally, the focus on precision medicine and oncology research is further increasing the demand for regenerative medicine. Therefore, such factors are expected to drive the growth of regenerative medicine in the oncology applications segment, which in turn is expected to propel the growth of the market during the forecast period.

Technology Segment Analysis

Cell and tissue-based

Cell therapy involves administering living cells to a single body to restore function to diseased or damaged body organs. The focus of cell- and tissue-based therapies is to repair and maintain the function of cells and tissues damaged by the development of various diseases such as cardiovascular diseases, cancer, musculoskeletal diseases, eye diseases, orthopedic diseases, neurological diseases, wounds and skin damage. However, regenerative therapy is only recommended for people who have no other treatment options. Approval of various new tissue-based regenerative medical devices and rising emphasis of companies on research and development to develop new cell- and tissue-based therapeutics will increase the cell- and tissue-based therapy segment during the forecast period. expected to be promoted.

Buy Now Full Report and Discover More

Japan Key Regenerative Medicine Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Terumo Corp.: The company offers regenerative medicine such as Finia fill and finish system, Quantum cell expansion system and spectra Optia apheresis system.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Japan Regenerative Medicine Market Growth and Future Trends

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key trends, and challenges.

Japan Significant Regenerative Medicine Market Trends

Increasing number of clinical trials is the primary trend shaping the growth of the market. The increase in the number of clinical trials is mainly due to increased efforts and support from various international and national public and private associations. Many regenerative medicine products are in various stages of clinical trials, from discovery or preclinical to mid- and late-stage.

Furthermore, the significant increase in the number of clinical trials suggests that healthcare providers are increasingly focusing on regenerative medicine research and development. Increasing the number of products successfully completing clinical trials and receiving product approval will drive Japan - regenerative medicine market growth. There are few products in late-stage (Phase III) clinical trials that are anticipated to propel growth in Japan's regenerative medicine market

Japan Major Regenerative Medicine Market Challenges

The scarcity of tissue donors is a challenge that affects the growth of the market. Market players that simulate regenerative products depend heavily on the availability of tissue from human donors. Several potential donor families may be reluctant to donate tissue to commercial tissue processors. Additionally, many suppliers are facing human tissue supply shortages due to limited control over availability, quality, and delivery times.

Therefore, any interruption in the supply of human tissue components will negatively impact the supplier's ability to produce regenerative products until a new source is found. Therefore, the lack of tissue donors is restricting the growth of the Japanese regenerative medicine market.

Buy Now Full Report and Discover More

Japan Key Regenerative Medicine Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Japan Regenerative Medicine Market Customer Landscape

Segment Overview

The Japan regenerative medicine market report forecasts market growth by revenue and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

Application Outlook (USD Million, 2017 - 2027)
- Oncology
- Musculoskeletal
- Dermatology
- Immunology and Inflammation and others

Technology Outlook (USD Million, 2017 - 2027)
- Cell and tissue-based
- Gene therapy

Japan Regenerative Medicine Market Scope
Report Coverage	Details
Page number	127
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 15.89%
Market growth 2023-2027	USD 2,328.47 million
Market structure	Fragmented
YoY growth 2022-2023(%)	14.75
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Astellas Pharma Inc., Becton Dickinson and Co., CellSeed Inc., Cellusion Inc., Cyfuse Biomedical K.K., F. Hoffmann La Roche Ltd., FUJIFILM Corp., HEALIOS K.K., iHeart Japan Corp., Japan Tissue Engineering Co. Ltd., JCR Pharmaceticals Co. Ltd., MEDINET Co. Ltd., Metcela Inc., Nikon Corp., ROHTO Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., Takara Bio Inc., Takeda Pharmaceutical Co. Ltd., Terumo Corp., and Yokogawa Electric Corp.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Japan Regenerative Medicine Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the Japan regenerative medicine market between 2023 and 2027
Precise estimation of the regenerative medicine market in Japan size and its contribution to the market in focus on the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies' position and classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across Japan
A thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of Japan regenerative medicine market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Country Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
- Exhibit 06: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 07: Parent market
- Exhibit 08: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 09: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 10: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
- Exhibit 11: Chart on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 12: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 13: Chart on Japan: Year-over-year growth 2022-2027 (%)
- Exhibit 14: Data Table on Japan: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Regenerative medicine market in Japan 2017 - 2021
- Exhibit 15: Historic Market Size – Data Table on regenerative medicine market in Japan 2017 - 2021 ($ million)

4.2 Application Segment Analysis 2017 - 2021
- Exhibit 16: Historic Market Size – Application Segment 2017 - 2021 ($ million)

4.3 Technology Segment Analysis 2017 - 2021
- Exhibit 17: Historic Market Size – Technology Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 18: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
- Exhibit 19: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
- Exhibit 20: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
- Exhibit 21: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
- Exhibit 22: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
- Exhibit 23: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition
- Exhibit 24: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 25: Chart on Application - Market share 2022-2027 (%)
- Exhibit 26: Data Table on Application - Market share 2022-2027 (%)

6.2 Comparison by Application
- Exhibit 27: Chart on Comparison by Application
- Exhibit 28: Data Table on Comparison by Application

6.3 Oncology - Market size and forecast 2022-2027
- Exhibit 29: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
- Exhibit 30: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
- Exhibit 31: Chart on Oncology - Year-over-year growth 2022-2027 (%)
- Exhibit 32: Data Table on Oncology - Year-over-year growth 2022-2027 (%)

6.4 Musculoskeletal - Market size and forecast 2022-2027
- Exhibit 33: Chart on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
- Exhibit 34: Data Table on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Chart on Musculoskeletal - Year-over-year growth 2022-2027 (%)
- Exhibit 36: Data Table on Musculoskeletal - Year-over-year growth 2022-2027 (%)

6.5 Dermatology - Market size and forecast 2022-2027
- Exhibit 37: Chart on Dermatology - Market size and forecast 2022-2027 ($ million)
- Exhibit 38: Data Table on Dermatology - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Chart on Dermatology - Year-over-year growth 2022-2027 (%)
- Exhibit 40: Data Table on Dermatology - Year-over-year growth 2022-2027 (%)

6.6 Immunology and Inflammation and others - Market size and forecast 2022-2027
- Exhibit 41: Chart on Immunology and Inflammation and others - Market size and forecast 2022-2027 ($ million)
- Exhibit 42: Data Table on Immunology and Inflammation and others - Market size and forecast 2022-2027 ($ million)
- Exhibit 43: Chart on Immunology and Inflammation and others - Year-over-year growth 2022-2027 (%)
- Exhibit 44: Data Table on Immunology and Inflammation and others - Year-over-year growth 2022-2027 (%)

6.7 Market opportunity by Application
- Exhibit 45: Market opportunity by Application ($ million)
- Exhibit 46: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Technology

7.1 Market segments
- Exhibit 47: Chart on Technology - Market share 2022-2027 (%)
- Exhibit 48: Data Table on Technology - Market share 2022-2027 (%)

7.2 Comparison by Technology
- Exhibit 49: Chart on Comparison by Technology
- Exhibit 50: Data Table on Comparison by Technology

7.3 Cell and tissue-based - Market size and forecast 2022-2027
- Exhibit 51: Chart on Cell and tissue-based - Market size and forecast 2022-2027 ($ million)
- Exhibit 52: Data Table on Cell and tissue-based - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Chart on Cell and tissue-based - Year-over-year growth 2022-2027 (%)
- Exhibit 54: Data Table on Cell and tissue-based - Year-over-year growth 2022-2027 (%)

7.4 Gene therapy - Market size and forecast 2022-2027
- Exhibit 55: Chart on Gene therapy - Market size and forecast 2022-2027 ($ million)
- Exhibit 56: Data Table on Gene therapy - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Chart on Gene therapy - Year-over-year growth 2022-2027 (%)
- Exhibit 58: Data Table on Gene therapy - Year-over-year growth 2022-2027 (%)

7.5 Market opportunity by Technology
- Exhibit 59: Market opportunity by Technology ($ million)
- Exhibit 60: Data Table on Market opportunity by Technology ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 61: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Drivers, Challenges, and Trends

9.1 Market drivers

9.2 Market challenges

9.3 Impact of drivers and challenges
- Exhibit 62: Impact of drivers and challenges in 2022 and 2027

9.4 Market trends

10 Vendor Landscape

10.1 Overview

10.2 Vendor landscape
- Exhibit 63: Overview on Criticality of inputs and Factors of differentiation

10.3 Landscape disruption
- Exhibit 64: Overview on factors of disruption

10.4 Industry risks
- Exhibit 65: Impact of key risks on business

11 Vendor Analysis

11.1 Vendors covered
- Exhibit 66: Vendors covered

11.2 Market positioning of vendors
- Exhibit 67: Matrix on vendor position and classification

11.3 Astellas Pharma Inc.
- Exhibit 68: Astellas Pharma Inc. - Overview
- Exhibit 69: Astellas Pharma Inc. - Product / Service
- Exhibit 70: Astellas Pharma Inc. - Key news
- Exhibit 71: Astellas Pharma Inc. - Key offerings

11.4 Becton Dickinson and Co.
- Exhibit 72: Becton Dickinson and Co. - Overview
- Exhibit 73: Becton Dickinson and Co. - Business segments
- Exhibit 74: Becton Dickinson and Co. - Key news
- Exhibit 75: Becton Dickinson and Co. - Key offerings
- Exhibit 76: Becton Dickinson and Co. - Segment focus

11.5 CellSeed Inc.
- Exhibit 77: CellSeed Inc. - Overview
- Exhibit 78: CellSeed Inc. - Product / Service
- Exhibit 79: CellSeed Inc. - Key offerings

11.6 Cyfuse Biomedical K.K.
- Exhibit 80: Cyfuse Biomedical K.K. - Overview
- Exhibit 81: Cyfuse Biomedical K.K. - Product / Service
- Exhibit 82: Cyfuse Biomedical K.K. - Key offerings

11.7 F. Hoffmann La Roche Ltd.
- Exhibit 83: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 84: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 85: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 86: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 87: F. Hoffmann La Roche Ltd. - Segment focus

11.8 FUJIFILM Corp.
- Exhibit 88: FUJIFILM Corp. - Overview
- Exhibit 89: FUJIFILM Corp. - Business segments
- Exhibit 90: FUJIFILM Corp. - Key news
- Exhibit 91: FUJIFILM Corp. - Key offerings
- Exhibit 92: FUJIFILM Corp. - Segment focus

11.9 iHeart Japan Corp.
- Exhibit 93: iHeart Japan Corp. - Overview
- Exhibit 94: iHeart Japan Corp. - Product / Service
- Exhibit 95: iHeart Japan Corp. - Key offerings

11.10 JCR Pharmaceticals Co. Ltd.
- Exhibit 96: JCR Pharmaceticals Co. Ltd. - Overview
- Exhibit 97: JCR Pharmaceticals Co. Ltd. - Product / Service
- Exhibit 98: JCR Pharmaceticals Co. Ltd. - Key offerings

11.11 Nikon Corp.
- Exhibit 99: Nikon Corp. - Overview
- Exhibit 100: Nikon Corp. - Business segments
- Exhibit 101: Nikon Corp. - Key news
- Exhibit 102: Nikon Corp. - Key offerings
- Exhibit 103: Nikon Corp. - Segment focus

11.12 ROHTO Pharmaceutical Co. Ltd.
- Exhibit 104: ROHTO Pharmaceutical Co. Ltd. - Overview
- Exhibit 105: ROHTO Pharmaceutical Co. Ltd. - Business segments
- Exhibit 106: ROHTO Pharmaceutical Co. Ltd. - Key offerings
- Exhibit 107: ROHTO Pharmaceutical Co. Ltd. - Segment focus

11.13 Sumitomo Pharma Co. Ltd.
- Exhibit 108: Sumitomo Pharma Co. Ltd. - Overview
- Exhibit 109: Sumitomo Pharma Co. Ltd. - Business segments
- Exhibit 110: Sumitomo Pharma Co. Ltd. - Key offerings
- Exhibit 111: Sumitomo Pharma Co. Ltd. - Segment focus

11.14 Takara Bio Inc.
- Exhibit 112: Takara Bio Inc. - Overview
- Exhibit 113: Takara Bio Inc. - Product / Service
- Exhibit 114: Takara Bio Inc. - Key offerings

11.15 Takeda Pharmaceutical Co. Ltd.
- Exhibit 115: Takeda Pharmaceutical Co. Ltd. - Overview
- Exhibit 116: Takeda Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Key news
- Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Key offerings

11.16 Terumo Corp.
- Exhibit 119: Terumo Corp. - Overview
- Exhibit 120: Terumo Corp. - Business segments
- Exhibit 121: Terumo Corp. - Key news
- Exhibit 122: Terumo Corp. - Key offerings
- Exhibit 123: Terumo Corp. - Segment focus

11.17 Yokogawa Electric Corp.
- Exhibit 124: Yokogawa Electric Corp. - Overview
- Exhibit 125: Yokogawa Electric Corp. - Business segments
- Exhibit 126: Yokogawa Electric Corp. - Key offerings
- Exhibit 127: Yokogawa Electric Corp. - Segment focus

12 Appendix

12.1 Scope of the report

12.2 Inclusions and exclusions checklist
- Exhibit 128: Inclusions checklist
- Exhibit 129: Exclusions checklist

12.3 Currency conversion rates for US$
- Exhibit 130: Currency conversion rates for US$

12.4 Research methodology
- Exhibit 131: Research methodology
- Exhibit 132: Validation techniques employed for market sizing
- Exhibit 133: Information sources

12.5 List of abbreviations
- Exhibit 134: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

regenerative medicine market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis